FDA Application
-
NDC Search Results on Active Ingredient: doxorubicin
Click on Active Ingredient to view the label.
| Ingredient Name | NDC | Company Name | Application Number or Regulatory Citation | Product Type | Marketing Category |
|---|---|---|---|---|---|
| DOXORUBICIN HYDROCHLORIDE | 45963-733-68 | Actavis Pharma, Inc. | ANDA203622 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 45963-733-57 | Actavis Pharma, Inc. | ANDA203622 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 45963-733-60 | Actavis Pharma, Inc. | ANDA203622 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 45963-733-55 | Actavis Pharma, Inc. | ANDA203622 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 70121-1218-1 | Amneal Pharmaceuticals LLC | ANDA208888 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 70121-1219-1 | Amneal Pharmaceuticals LLC | ANDA208888 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 70121-1218-7 | Amneal Pharmaceuticals LLC | ANDA208888 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 70860-208-05 | Athenex Pharmaceutical Division, LLC. | ANDA209825 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 70860-208-25 | Athenex Pharmaceutical Division, LLC. | ANDA209825 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 70860-208-51 | Athenex Pharmaceutical Division, LLC. | ANDA209825 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 0338-0086-01 | Baxter Healthcare Corporation | NDA050718 | HUMAN PRESCRIPTION DRUG | NDA authorized generic |
| DOXORUBICIN HYDROCHLORIDE | 0338-9581-01 | Baxter Healthcare Corporation | HUMAN PRESCRIPTION DRUG | Unapproved drug for use in drug shortage | |
| DOXORUBICIN HYDROCHLORIDE | 0338-0067-01 | Baxter Healthcare Corporation | NDA050718 | HUMAN PRESCRIPTION DRUG | NDA |
| DOXORUBICIN HYDROCHLORIDE | 0338-0063-01 | Baxter Healthcare Corporation | NDA050718 | HUMAN PRESCRIPTION DRUG | NDA |
| DOXORUBICIN HYDROCHLORIDE | 0338-9581-02 | Baxter Healthcare Corporation | HUMAN PRESCRIPTION DRUG | Unapproved drug for use in drug shortage | |
| DOXORUBICIN HYDROCHLORIDE | 0338-0080-01 | Baxter Healthcare Corporation | NDA050718 | HUMAN PRESCRIPTION DRUG | NDA authorized generic |
| DOXORUBICIN HYDROCHLORIDE | 68001-492-36 | BluePoint Laboratories | ANDA203263 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 68001-345-36 | BluePoint Laboratories | ANDA208657 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 68001-345-26 | BluePoint Laboratories | ANDA208657 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 68001-493-26 | BluePoint Laboratories | ANDA203263 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 43598-541-25 | Dr. Reddy's Laboratories Inc | ANDA208657 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 43598-682-35 | Dr. Reddy's Laboratories Inc | ANDA208657 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 43598-283-35 | Dr. Reddy's Laboratories Inc | ANDA208657 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 43598-683-25 | Dr. Reddy's Laboratories Inc | ANDA208657 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 63323-883-30 | Fresenius Kabi USA, LLC | ANDA063277 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 63323-883-05 | Fresenius Kabi USA, LLC | ANDA063277 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 63323-101-61 | Fresenius Kabi USA, LLC | ANDA063277 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 63323-883-10 | Fresenius Kabi USA, LLC | ANDA063277 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 68083-249-01 | Gland Pharma Limited | ANDA209825 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 68083-248-01 | Gland Pharma Limited | ANDA209825 | HUMAN PRESCRIPTION DRUG | ANDA |
| 1-30 | 31-60 | 61-78 |
-
